DURECT (DRRX) Stock Price
$0.799 0%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
1 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on DURECT, AI stock picks, stock alerts and much more.
DRRX AI Stock Analysis
AI stock analysis for DRRX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like DURECT (DRRX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
DURECT (DRRX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of DURECT (DRRX), currently trading at $0.799, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About DRRX
-
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs.
-
Symbol
DRRX
-
Market
NASDAQ
-
Industry
Drug Manufacturers - Specialty & Generic
-
Market Cap
24.8M
Similar Stocks
 |
TherapeuticsMD TXMD |
$1.3 28.7% |
4 |
 |
Tilray TLRY |
$0.9515 9.7% |
3 |
 |
Canopy Growth CGC |
$1.63 1.2% |
2 |
 |
Aurora Cannabis ACB |
$5.89 0.5% |
4 |
 |
Sundial Growers SNDL |
$1.77 0.6% |
3 |
News
DRRX Alternative Data
Web Traffic
DURECT receives an estimated 3262 monthly visitors to durect.com.
-
Web Traffic
3262
-
Change from Previous Month
24.1%
-
3 Month Change
58.6%
-
YoY Change
58.6%
News Mentions
DURECT was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
Reddit Mentions
DURECT has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
DURECT has 358 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
358
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
10.3%
Job Postings
DURECT currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, DURECT has 100 employees.
-
LinkedIn Employees
100
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
2.9%
DRRX Financials
DRRX Key Metrics
-
Total Revenue
$1.9M
-
Net Income
-$4.3M
-
Earnings per Share
-$0.14
-
Free cash flow
-$3.1M
-
EBITDA
-$3.9M
-
EBITDA Ratio
-2.02283
-
Total Assets
$24.1M
DRRX 2-year Revenue & Income
DRRX 2-year Free Cash Flow
DRRX Technicals
DRRX SMA
DRRX RSI
FAQ
What's the current price of DURECT (DRRX) Stock?
The price of an DURECT (DRRX) share is $0.799.
What's the market cap of DURECT?
The current market cap of DURECT is 24.8M.
Should I buy or sell DRRX?
DURECT exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is DURECT a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in DURECT stock. There are several bearish signals and market challenges that could negatively impact DURECT's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy DURECT (DRRX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy DURECT stock right now, as the outlook appears bearish.
What are some stocks similar to DURECT (DRRX) that investors often compare it to?
DURECT (DRRX) is often compared to similar stocks such as TherapeuticsMD, Tilray, Canopy Growth, Aurora Cannabis and Sundial Growers.
What is the forecast for DURECT's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast DURECT's stock price to be around $0.752 in 2026. Starting from the current price of $0.799, this represents a 5.9% change in price, indicating a bearish outlook for the stock.
How to buy DURECT (DRRX) Stock?
DURECT stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy DURECT shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.